Filing Details

Accession Number:
0001209191-23-009301
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-14 17:40:07
Reporting Period:
2023-02-10
Accepted Time:
2023-02-14 17:40:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Medical Laboratories (8071) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306119 T Kevin Conroy C/O Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-10 9,705 $0.00 1,177,632 No 4 M Direct
Common Stock Disposition 2023-02-13 4,527 $64.55 1,173,105 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Disposition 2023-02-10 9,705 $0.00 9,705 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 27,099 Indirect Held in 401(k) Plan
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,729 Indirect Held in Grantor Retained Annuity Trust
Footnotes
  1. Represents shares of common stock received upon settlement of a performance share unit award (the "PSU Award") on February 10, 2023, which is described further in Footnote 5 to this Form 4.
  2. Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units on February 10, 2023.
  3. In addition to the shares of Common Stock reported on this Form 4, which total 1,265,393 shares, Mr. Conroy also holds, in the aggregate, an additional 761,440 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  4. Each Performance Share Unit represents a right to receive one share of common stock.
  5. On February 22, 2022, Mr. Conroy agreed to accept performance vesting stock units ("PSUs") in lieu of one-half of his bonus opportunity for 2022. The amount of the PSUs that ultimately vested was equal to the percentage of the bonus opportunity that was paid to bonus plan participants based on the achievement of corporate goals established for such plan.